As of 2025-05-16, the Relative Valuation of Natco Pharma Ltd (NATCOPHARM.NS) is 3,383.21 INR. This relative valuation is based on P/E multiples. With the latest stock price at 823.80 INR, the upside of Natco Pharma Ltd based on Relative Valuation is 310.7%.
The range of the Relative Valuation is 2,896.66 - 3,961.16 INR.
| Range | Selected | |
| Trailing P/E multiples | 35.8x - 38.0x | 36.5x |
| Forward P/E multiples | 31.5x - 33.2x | 32.2x |
| Fair Price | 2,896.66 - 3,961.16 | 3,383.21 |
| Upside | 251.6% - 380.8% | 310.7% |
| Date | P/E |
| 2025-05-15 | 7.91 |
| 2025-05-14 | 7.96 |
| 2025-05-13 | 7.92 |
| 2025-05-12 | 8.05 |
| 2025-05-09 | 7.78 |
| 2025-05-08 | 7.69 |
| 2025-05-07 | 7.83 |
| 2025-05-06 | 7.97 |
| 2025-05-05 | 8.21 |
| 2025-05-02 | 8.06 |
| 2025-04-30 | 8.16 |
| 2025-04-29 | 8.48 |
| 2025-04-28 | 8.49 |
| 2025-04-25 | 8.55 |
| 2025-04-24 | 8.66 |
| 2025-04-23 | 8.11 |
| 2025-04-22 | 8.06 |
| 2025-04-21 | 7.98 |
| 2025-04-17 | 7.95 |
| 2025-04-16 | 7.96 |
| 2025-04-15 | 7.74 |
| 2025-04-11 | 7.47 |
| 2025-04-09 | 7.17 |
| 2025-04-08 | 7.44 |
| 2025-04-07 | 7.40 |
| 2025-04-04 | 7.66 |
| 2025-04-03 | 8.06 |
| 2025-04-02 | 7.76 |
| 2025-04-01 | 7.73 |
| 2025-03-28 | 7.68 |
| 2025-03-27 | 7.88 |
| 2025-03-26 | 7.89 |
| 2025-03-25 | 7.90 |
| 2025-03-24 | 7.98 |
| 2025-03-21 | 7.97 |
| 2025-03-20 | 7.95 |
| 2025-03-19 | 7.97 |
| 2025-03-18 | 7.77 |
| 2025-03-17 | 7.69 |
| 2025-03-13 | 7.49 |
| 2025-03-12 | 7.52 |
| 2025-03-11 | 7.61 |
| 2025-03-10 | 7.79 |
| 2025-03-07 | 7.91 |
| 2025-03-06 | 7.90 |
| 2025-03-05 | 7.86 |
| 2025-03-04 | 7.71 |
| 2025-03-03 | 7.67 |
| 2025-02-28 | 7.42 |
| 2025-02-27 | 7.62 |